|
2026
|
Invention
|
Methods for producing molecules.
Methods are disclosed for producing a molecule comprising a pol... |
|
|
Invention
|
Method for decelerating the decay-dissociation of c3bbb complex.
The present invention relates t... |
|
|
Invention
|
Mutant transaminase with increased asymmetric reductive amination activity as well as methods and... |
|
|
Invention
|
Device and method for handling biological entities. A device for handling biological entities (1)... |
|
|
Invention
|
Combination therapies for use in the treatment of breast cancer. Provided are combination therapi... |
|
|
Invention
|
Novel compounds.
The invention relates to novel compounds having the general formula I
The inv... |
|
|
Invention
|
Antibodies binding to cd3. The present invention generally relates to antibodies that bind to CD3... |
|
|
Invention
|
Artificial antigen presenting cell line. The present invention provides an artificial antigen pre... |
|
|
Invention
|
Method for the generation of single stranded dna. The present invention relates to a method for t... |
|
|
Invention
|
Pharmaceutical compositions comprising an antibiotic macrocyclic peptide. The present invention r... |
|
|
Invention
|
Method for the analysis of cerebrospinal fluid (csf) samples. The present invention provides a fl... |
|
|
Invention
|
Tyk2 degraders. The present invention provides a compound of formula I or a pharmaceutically acce... |
|
|
Invention
|
Sarm1 inhibitors. The invention provides compounds having the general formula (I) or (II) wherein... |
|
|
Invention
|
Antibiotic macrocyclic peptides. The present invention provides compounds of formula (I); (I) whe... |
|
|
Invention
|
Process for the preparation of a bsmoc-lys fatty acid compound. The invention relates to a proces... |
|
|
Invention
|
Antibiotic macrocyclic peptides. The present invention provides compounds of formula (I): (I) whe... |
|
|
Invention
|
Sarm1 inhibitors. The invention provides compounds having the general formula (I), (II), or (III)... |
|
2025
|
Invention
|
Treatment of inflammatory lung disease and therapeutic agents useful therefor.
The present inven... |
|
|
Invention
|
Antibodies binding to tn-muc-1. The present invention generally relates to antibodies that bind t... |
|
|
Invention
|
Fluid conveying arrangement, recipient system and method for providing a fluid flow in a recipien... |
|
|
Invention
|
Process for the preparation of oxetane derivatives. The present invention relates to a new proces... |
|
|
Invention
|
Antisense oligonucleotides targeting downstream of the transcripts 3' terminus. The present inven... |
|
|
Invention
|
Sample holder, mould and methods for preparing a sample holder and tissue samples for histologica... |
|
|
Invention
|
Treatment of inflammatory lung disease by combined inhibition of il-33 and il-6 with bispecific a... |
|
|
Invention
|
Decontamination system for a mobile apparatus, room and method involving such system. A decontami... |
|
|
Invention
|
Aav particle processing using affinity chromatography with gradient elution. Herein is reported a... |
|
|
Invention
|
Purification process for viral vectors. Herein is reported a method for separating recombinant vi... |
|
|
Invention
|
Process for the preparation of a fatty acid compound. The invention relates to a process for the ... |
|
|
Invention
|
Double stranded oligonucleotide for modulating jak1 expression. The present invention relates to ... |
|
|
Invention
|
Cannabinoid receptor 2 modulators.
The present invention provides compounds that are useful as m... |
|
|
Invention
|
Agonistic split antibodies.
The application relates to pairs of antigen binding molecules, each ... |
|
|
Invention
|
Multispecific antibodies.
The present invention relates to multispecific antibodies, their manuf... |
|
|
Invention
|
Modified aav particles.
Herein is reported a novel variant adeno-associated virus (AAV) capsid p... |
|
|
Invention
|
Multispecific antibodies.
The present invention relates to multispecific antibodies, methods for... |
|
|
Invention
|
Antibodies that specifically bind modified oligonucleotides.
Herein is reported an anti-LNA anti... |
|
2024
|
G/S
|
Antibiotic Preparation |
|
2023
|
Invention
|
Processes for the preparation of nlrp3 inhibitors.
The present invention relates to intermediate... |
|
|
Invention
|
Combination therapy for cancer treatment.
Provided herein are combination therapies comprising a... |
|
|
Invention
|
Cd47 blocking agent and anti-cd20 / anti-cd3 bispecific antibody combination therapy.
Dosing reg... |
|
|
Invention
|
Novel compounds as modulators of nlrp3 inhibition.
The invention relates to novel compounds havi... |
|
|
Invention
|
Aryl thioethers as hif-2alpha inhibitors.
The present invention provides novel compounds having ... |
|
|
Invention
|
Triazinone derivatives as nlrp3 inhibitors.
The invention relates to novel compounds having the ... |
|
|
Invention
|
Triazinone derivatives as nlrp3 inhibitors.
The invention relates to a novel compound having the... |
|
|
Invention
|
Combination therapy with anti-cd19/anti-cd28 bispecific antibody.
The present invention relates ... |
|
|
Invention
|
Benzamide compounds for treatment of bacterial infections.
The present invention relates to comp... |
|
2022
|
Invention
|
Method of extracting information about protein sequence modifications.
Methods of extracting inf... |
|
|
G/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
2019
|
G/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
G/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
G/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
G/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
G/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
G/S
|
full line of pharmaceutical preparations |
|
|
G/S
|
pharmaceutical antiviral preparation |
|
2000
|
G/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
G/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
G/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
G/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
G/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
G/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
G/S
|
Clinical Laboratory Services |
|
1977
|
G/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
G/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
G/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
G/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
